Céline Louapre1, Sindhuja T Govindarajan2, Costanza Giannì1, Nancy Madigan3, Jacob A Sloane4, Constantina A Treaba1, Elena Herranz1, Revere P Kinkel5, Caterina Mainero1. 1. A. A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Boston, MA, USA/Harvard Medical School, Boston, MA, USA. 2. A. A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Boston, MA, USA. 3. Beth Israel Deaconess Medical Center, Boston, MA, USA. 4. Harvard Medical School, Boston, MA, USA; Beth Israel Deaconess Medical Center, Boston, MA, USA. 5. Department of Neuroscience, University of California San Diego, San Diego, CA, USA.
Abstract
BACKGROUND: Thalamic degeneration impacts multiple sclerosis (MS) prognosis. OBJECTIVE: To investigate heterogeneous thalamic pathology, its correlation with white matter (WM), cortical lesions and thickness, and as function of distance from cerebrospinal fluid (CSF). METHODS: In 41 MS subjects and 17 controls, using 3 and 7 T imaging, we tested for (1) differences in thalamic volume and quantitative T2* (q-T2*) (2) globally and (3) within concentric bands originating from the CSF/thalamus interface; (4) the relation between thalamic, cortical, and WM metrics; and (5) the contribution of magnetic resonance imaging (MRI) metrics to clinical scores. We also assessed MS thalamic lesion distribution as a function of distance from CSF. RESULTS: Thalamic lesions were mainly located next to the ventricles. Thalamic volume was decreased in MS versus controls ( p < 10-2); global q-T2* was longer in secondary progressive multiple sclerosis (SPMS) only ( p < 10-2), indicating myelin and/or iron loss. Thalamic atrophy and longer q-T2* correlated with WM lesion volume ( p < 0.01). In relapsing-remitting MS, q-T2* thalamic abnormalities were located next to the WM ( p < 0.01 (uncorrected), p = 0.09 (corrected)), while they were homogeneously distributed in SPMS. Cortical MRI metrics were the strongest predictors of clinical outcome. CONCLUSION: Heterogeneous pathological processes affect the thalamus in MS. While focal lesions are likely mainly driven by CSF-mediated factors, overall thalamic degeneration develops in association with WM lesions.
BACKGROUND:Thalamic degeneration impacts multiple sclerosis (MS) prognosis. OBJECTIVE: To investigate heterogeneous thalamic pathology, its correlation with white matter (WM), cortical lesions and thickness, and as function of distance from cerebrospinal fluid (CSF). METHODS: In 41 MS subjects and 17 controls, using 3 and 7 T imaging, we tested for (1) differences in thalamic volume and quantitative T2* (q-T2*) (2) globally and (3) within concentric bands originating from the CSF/thalamus interface; (4) the relation between thalamic, cortical, and WM metrics; and (5) the contribution of magnetic resonance imaging (MRI) metrics to clinical scores. We also assessed MS thalamic lesion distribution as a function of distance from CSF. RESULTS: Thalamic lesions were mainly located next to the ventricles. Thalamic volume was decreased in MS versus controls ( p < 10-2); global q-T2* was longer in secondary progressive multiple sclerosis (SPMS) only ( p < 10-2), indicating myelin and/or iron loss. Thalamic atrophy and longer q-T2* correlated with WM lesion volume ( p < 0.01). In relapsing-remitting MS, q-T2* thalamic abnormalities were located next to the WM ( p < 0.01 (uncorrected), p = 0.09 (corrected)), while they were homogeneously distributed in SPMS. Cortical MRI metrics were the strongest predictors of clinical outcome. CONCLUSION: Heterogeneous pathological processes affect the thalamus in MS. While focal lesions are likely mainly driven by CSF-mediated factors, overall thalamic degeneration develops in association with WM lesions.
Authors: Vincent Planche; Jason H Su; Sandy Mournet; Manojkumar Saranathan; Vincent Dousset; May Han; Brian K Rutt; Thomas Tourdias Journal: Mult Scler Date: 2019-02-07 Impact factor: 6.312
Authors: Niels Bergsland; Ferdinand Schweser; Michael G Dwyer; Bianca Weinstock-Guttman; Ralph H B Benedict; Robert Zivadinov Journal: Hum Brain Mapp Date: 2018-06-19 Impact factor: 5.038
Authors: Ambica Mehndiratta; Constantina A Treaba; Valeria Barletta; Elena Herranz; Russell Ouellette; Jacob A Sloane; Eric C Klawiter; Revere P Kinkel; Caterina Mainero Journal: Mult Scler Date: 2020-06-25 Impact factor: 6.312
Authors: Dejan Jakimovski; Niels Bergsland; Michael G Dwyer; Jesper Hagemeier; Deepa P Ramasamy; Kinga Szigeti; Thomas Guttuso; David Lichter; David Hojnacki; Bianca Weinstock-Guttman; Ralph H B Benedict; Robert Zivadinov Journal: Neurobiol Aging Date: 2020-02-08 Impact factor: 4.673
Authors: Ferdinand Schweser; Jesper Hagemeier; Michael G Dwyer; Niels Bergsland; Simon Hametner; Bianca Weinstock-Guttman; Robert Zivadinov Journal: Hum Brain Mapp Date: 2020-12-30 Impact factor: 5.038
Authors: Merlin M Weeda; Ilanah J Pruis; Aimee S R Westerveld; Iman Brouwer; Barbara Bellenberg; Frederik Barkhof; Hugo Vrenken; Carsten Lukas; Ruth Schneider; Petra J W Pouwels Journal: Front Neurol Date: 2020-11-17 Impact factor: 4.003